期刊文献+

利妥昔单抗相关的间质性肺炎文献复习:附2例报告 被引量:14

Rituximab-induced interstitial pneumonitis: report of two cases and literature review
下载PDF
导出
摘要 目的学习总结利妥昔单抗(美罗华,RTX)相关的间质性肺炎(RTX-IP)的疾病特点、发病机制及诊疗方法。方法通过相关检查并结合文献回顾,对2例在使用RTX治疗过程中发生IP的淋巴瘤患者进行病例分析及治疗。结果 2例患者在治疗后间质性肺炎病灶消失,后续原发病治疗过程顺利。结论 RTX-IP起病隐匿,病理机制不明,症状不典型,需引起临床医生重视。高分辨CT对其早期发现应用价值高,RTX增加了患者对机会菌的易感性可能是部分患者的发病机制。 We report two cases of rituximab(RTX)- induced interstitial pneumonia in two lymphoma patients receiving RTX treatment. Interstitial pneumonia was successfully managed in these two cases after a one- week- long intervention with corresponding treatments without affecting further treatment of the primary disease. RTX- induced interstitial pneumonia is characterized by a latent onset with an unclear pathological mechanism and absence of typical symptoms. High-resolution CT scan can provide valuable evidence for early diagnosis of RTX- induced interstitial pneumonia, which might be attributed partially to an increased susceptibility to P. jirovecii and fungal infection due to prolonged RTX treatment.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2015年第1期129-132,共4页 Journal of Southern Medical University
基金 国防科工委专项课题分题(B3320062101)
关键词 利妥昔单抗 间质性肺炎 淋巴瘤 rituximab interstitial pneumonia lymphoma
  • 相关文献

参考文献26

  • 1Wagner SA, Mehta AC, Laber DA. Rituximab-induced interstitial lung disease[J]. Am J Hematol, 2007, 82(10): 916-9.
  • 2Herishanu Y, Polliack A, Leider-Trejo L, et al. Fatal interstitial pneumonitis related to rituximab-containing regimen [J]. Clin Lymphoma Myeloma, 2006, 6(5): 407-9.
  • 3Cha SI, Choi KJ, Shin KM, et al. Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma [J]. Respiration,2013, 85(2): 175.
  • 4Cheson BD, Leonard JP. Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma[J]. N Engl J Med, 2008, 359(6): 613-26.
  • 5Buske C, Hoster E, Dreyling M, et al. The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmaeytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG) ~J]. Leukemia, 2009, 23(1):153-61.
  • 6Arnold DM, Dentali F, Crowther MA, et al. Systematic review: efficacy and safety of dtuximab for adults with idiopathic thrombocytopenic purpura[J]. Ann Intern Med, 2007, 146(1): 25-33.
  • 7Sibilia J, Gottenberg J E, Mariette X. Rituximab: a new therapeutic alternative in rheumatoid arthritis[J]. Joint Bone Spine, 2008, 75(5): 526-32.
  • 8Zhou X, Hu W, Qin X. The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy[J]. Oncologist, 2008, 13(9): 954-66.
  • 9Burton C, Kaczmarski R, Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy [J]. N Engl J Med, 2003, 348(26): 2690-1.
  • 10Coiftier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma [J]. N Engl J Med, 2002, 346(4): 235-42.

同被引文献138

引证文献14

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部